These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23010734)

  • 1. Esophageal carcinosarcoma: a unique entity with better prognosis.
    Wang L; Lin Y; Long H; Liu H; Rao H; He Y; Rong T; Liang Y
    Ann Surg Oncol; 2013 Mar; 20(3):997-1004. PubMed ID: 23010734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and immunohistochemical characteristics of esophageal carcinosarcoma.
    Sano A; Sakurai S; Kato H; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Sakamoto K; Sano T; Hosoya Y; Enomoto T; Kanda T; Ajioka Y; Oyama T; Kuwano H
    Anticancer Res; 2009 Aug; 29(8):3375-80. PubMed ID: 19661359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial stage affects survival even after complete pathologic remission is achieved in locally advanced esophageal cancer: analysis of 70 patients with pathologic major response after preoperative chemoradiotherapy.
    Kim MK; Cho KJ; Park SI; Kim YH; Kim JH; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Song HJ; Ryu JS; Kim SB
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):115-21. PubMed ID: 19251379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic tumor length is an independent prognostic factor in esophageal squamous cell carcinoma.
    Wang BY; Liu CY; Lin CH; Hsu PK; Hsu WH; Wu YC; Cheng CY
    Ann Surg Oncol; 2012 Jul; 19(7):2149-58. PubMed ID: 22407313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma.
    Jung J; Park SY; Park SJ; Park J
    Tumour Biol; 2016 Jun; 37(6):7149-54. PubMed ID: 26662960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
    Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
    BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary esophageal adenosquamous carcinoma: a retrospective analysis of 24 cases.
    Zhang HD; Chen CG; Gao YY; Ma Z; Tang P; Duan XF; Ren P; Yue J; Yu ZT
    Dis Esophagus; 2014; 27(8):783-9. PubMed ID: 24127755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas.
    Miyata H; Yamasaki M; Kurokawa Y; Takiguchi S; Nakajima K; Fujiwara Y; Konishi K; Mori M; Doki Y
    Ann Surg Oncol; 2011 Nov; 18(12):3353-61. PubMed ID: 21537861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer.
    Sharaiha RZ; Halazun KJ; Mirza F; Port JL; Lee PC; Neugut AI; Altorki NK; Abrams JA
    Ann Surg Oncol; 2011 Nov; 18(12):3362-9. PubMed ID: 21547702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
    Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF
    Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery.
    Forget P; Machiels JP; Coulie PG; Berliere M; Poncelet AJ; Tombal B; Stainier A; Legrand C; Canon JL; Kremer Y; De Kock M
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S650-60. PubMed ID: 23884751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
    Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
    J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
    Zhou XL; Li YQ; Zhu WG; Yu CH; Song YQ; Wang WW; He DC; Tao GZ; Tong YS
    Sci Rep; 2017 Feb; 7():42581. PubMed ID: 28195186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer.
    Meredith KL; Weber JM; Turaga KK; Siegel EM; McLoughlin J; Hoffe S; Marcovalerio M; Shah N; Kelley S; Karl R
    Ann Surg Oncol; 2010 Apr; 17(4):1159-67. PubMed ID: 20140529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of esophageal cancer patients with pathologic complete response after preoperative concurrent chemoradiotherapy.
    Park JW; Kim JH; Choi EK; Lee SW; Yoon SM; Song SY; Lee YS; Kim SB; Park SI; Ahn SD
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):691-7. PubMed ID: 20888705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinosarcoma of the esophagus: a twenty-case study.
    Iyomasa S; Kato H; Tachimori Y; Watanabe H; Yamaguchi H; Itabashi M
    Jpn J Clin Oncol; 1990 Mar; 20(1):99-106. PubMed ID: 2319703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
    Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Predictive Value of Pretreatment Neutrophil-To-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma.
    Chen MF; Chen PT; Kuan FC; Chen WC
    Ann Surg Oncol; 2019 Jan; 26(1):190-199. PubMed ID: 30362062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil to lymphocyte ratio as prognostic indicator for patients with esophageal squamous cell cancer.
    Gao GD; Sun B; Wang XB; Wang SM
    Int J Biol Markers; 2017 Oct; 32(4):e409-e414. PubMed ID: 28799624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Ability of Blood Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Gastrointestinal Stromal Tumors.
    Racz JM; Cleghorn MC; Jimenez MC; Atenafu EG; Jackson TD; Okrainec A; Venkat Raghavan L; Quereshy FA
    Ann Surg Oncol; 2015 Jul; 22(7):2343-50. PubMed ID: 25472648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.